Disease Course and Treatment Responses in Children With RelapsingMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease


Hacohen Y., YiWong Y., Lechner C., Jurynczyk M., Wright S., KONUŞKAN B. , ...Daha Fazla

JAMA NEUROLOGY, cilt.75, ss.478-487, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 75 Konu: 4
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1001/jamaneurol.2017.4601
  • Dergi Adı: JAMA NEUROLOGY
  • Sayfa Sayıları: ss.478-487

Özet

IMPORTANCE Myelin oligodendrocyte glycoprotein antibodies (MOG-Abs) are consistently identified in a range of demyelinating disorders in adults and children. Current therapeutic strategies are largely center specific, and no treatments have been formally evaluated.